Original Source(s)
Related Content
ESMO26: Toni Choueiri, MD on LITESPARK-012
Surprising results in first triplet combination study in advanced kidney cancer presented by Toni Choueiri, MD, at #ESMO26. Dr. Choueiri says even though the combination did not improve efficacy, the findings are important for informing future studies.
November 17, 2026
-
1 min